Deutsches Herzzentrum Muenchen: Heart Diseases trials
The registry lists 14 Heart Diseases studies with Deutsches Herzzentrum Muenchen as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 4 11No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Digital Health Promotion for Children With Congenital Heart Disease and Their GuardiansRecruitingNCT06626672Not applicable
- Digital Health Nudging in Adolescents With Congenital Heart DiseaseCompletedNCT04933786Not applicable
- Web-based Motor Intervention to Increase Health Related Physical Fitness in Children With Congenital Heart DiseaseCompletedNCT03488797Not applicable
- ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence TomographyCompletedNCT01594736Phase 4
- Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function TestingStatus unknownNCT01456364Phase 4
- Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial FibrillationTerminatedNCT01352702Phase 4
- Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence TomographyStatus unknownNCT01260558Phase 4
- Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence TomographyStatus unknownNCT01230723Phase 4
- Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence TomographyCompletedNCT01097434Phase 4
- Test Efficacy of Biodegradable and Permanent Limus-Eluting StentsStatus unknownNCT01068106Phase 4
- Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent RestenosisCompletedNCT00987324Phase 4
- 3 Limus Agent Eluting Stents With Different Polymer CoatingCompletedNCT00598676Phase 4
- Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)CompletedNCT00402636Phase 4
- Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)CompletedNCT00350454Phase 4